Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You identify as Black or African American (including mixed-race with Black or African American heritage) — this can be based on your own self-report
- You have been told you have prostate cancer that has spread to other parts of the body (metastatic prostate cancer) — no formal pathology report is needed, your own report is acceptable
- You are able to understand what the study involves and are willing to follow the study procedures for the full duration
- You are fluent in English (reading, writing, and speaking)
- (For one part of the study only) Your cancer doctor expects that tumor genetic testing — such as analyzing cancer DNA from tissue or a blood sample — will be discussed with you within the next year of joining the study (confirm with trial site)
Who may not be able to join:
- You have a medical reason that would prevent you from safely taking part in any of the study's procedures or assessments (confirm with trial site for specifics)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel Kwon, MD, University of California, San Francisco
Phone: 877-827-3222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of participant responses (Stage 1); Proportion of enrolled participants (Stage 2); Proportion of enrolled participants who review all educational materials (Stage 2); Mean score of Feasibility of Intervention Measure (FIM) (Stage 2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.